Skip to main content

Animations

MJFF Publications

381 - 390 of 6560 Results
Title
Year
  • Year
  • 2020
  • 2025
  • 2025
  • 2020
  • 2022
  • 2020
  • 2015
  • 2019
  • 2023
  • 2020
  • Summary Details
    OPEN
    Title: Nonsteroidal Anti‐inflammatory Use and LRRK2 Parkinson's Disease Penetrance
    Journal Name: Movement Disorders
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/mds.28189
    Citation Count: 87
  • Summary Details
    OPEN
    Title: External delay and dispersion correction of automatically sampled arterial blood with dual flow rates
    Journal Name: Biomedical Physics & Engineering Express
    Publisher: IOP Publishing
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1088/2057-1976/adae13
    Citation Count: 2
  • Summary Details
    OPEN
    Title: Activation of endogenous PRKN by structural derepression is linked to increased turnover of the E3 ubiquitin ligase
    Journal Name: Autophagy
    Publisher: Informa UK Limited
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1080/15548627.2025.2531025
    Citation Count: 4
  • Summary Details
    OPEN
    Title: The tale of proteolysis targeting chimeras (PROTACs) for Leucine‐Rich Repeat Kinase 2 (LRRK2)
    Journal Name: ChemMedChem
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1002/cmdc.202000872
    Citation Count: 42
  • Summary Details
    OPEN
    Title: Gastric acid suppressants and cognitive decline in people with or without cognitive impairment
    Journal Name: Alzheimer's & Dementia: Translational Research & Clinical Interventions
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/trc2.12243
    Citation Count: 13
  • Summary Details
    OPEN
    Title: MIDN locus structural variants and Parkinson's Disease risk
    Journal Name: Annals of Clinical and Translational Neurology
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1002/acn3.51012
    Citation Count: 15
  • Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study
    2015
    Summary Details
    OPEN
    Title: Detecting and monitoring the symptoms of Parkinson's disease using smartphones: A pilot study
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2015.02.026
    Citation Count: 390
  • Summary Details
    OPEN
    Title: The role of phosphodiesterase 4 in excessive daytime sleepiness in Parkinson's disease
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.02.027
    Citation Count: 18
  • Summary Details
    OPEN
    Title: From policy to practice: Lessons learned from an open science funding initiative
    Journal Name: PLOS Computational Biology
    Publisher: Public Library of Science (PLoS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1371/journal.pcbi.1011626
    Citation Count: 5
  • Summary Details
    OPEN
    Title: Pathogenic Pathways in Early-Onset Autosomal Recessive Parkinson's Disease Discovered Using Isogenic Human Dopaminergic Neurons
    Journal Name: Stem Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.stemcr.2019.12.005
    Citation Count: 63
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.